The disease can cause it to become harder and harder to breathe - and it's key you keep an eye out for symptoms ...

Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim reported positive results from a similar phase 3 trial assessing its PDE4B ...

If you have a cough and are putting it down to 'just you' or 'that illness' you've had for weeks, you should see a GP, a ...

A study has found microscopic particles emitted from certain types of commonly fitted brake pads can be more toxic than those found in diesel vehicle exhaust.

In a recent transaction, Allen S. Melemed, the Chief Medical (TASE:PMCN) Officer of Chimerix Inc . (NASDAQ:CMRX), sold 3,065 shares of the company's common stock. The shares were sold at an average ...

Edesa anticipates topline results could be available within as few as 12 to 18 months following regulatory clearance by the FDA. Health Canada has previously granted approval to initiate this Phase 2 ...

Investorideas , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Life Sciences and AI sectors ...

Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a $1.03 billion market cap biotech company, executed sales of common stock valued at a total of $46,360 over two consecutive days, ...

Exposure to air pollution is associated with around 7 million premature deaths per year across the world. When we think of ...

Choreo LLC bought a new position in Verona Pharma plc (NASDAQ:VRNA – Free Report) during the 4th quarter, according to the ...